Which GLP-1 is Best for You: A Comprehensive Guide to GLP-1 Receptor Agonists

Last reviewed: June 16, 2026

Last updated: June 16, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

GLP-1 receptor agonists have transformed weight management by mimicking a hormone that controls appetite and blood sugar. Clinical trials show these medications produce 15-22% weight loss over 68 weeks, yet individual results depend on genetic factors and treatment approach. Understanding how different GLP-1 options work helps you make an informed decision with your healthcare provider.

How GLP-1 Receptor Agonists Work for Weight Loss

GLP-1 (glucagon-like peptide-1) receptor agonists activate brain centers that regulate hunger while slowing stomach emptying. This dual action reduces overall calorie intake without requiring willpower-dependent restriction. The medications also improve blood sugar control, which stabilizes energy levels and reduces cravings throughout the day.

Semaglutide and tirzepatide are the two primary active compounds in current GLP-1 therapy. Semaglutide targets the GLP-1 receptor exclusively, while tirzepatide also activates the GIP receptor for enhanced metabolic effects. PlexusDx offers both as single-compound therapies and as a dual-compound GLP-Squared option, allowing flexibility based on your response.

Semaglutide Injection vs. Oral: Choosing Your Delivery Method

Semaglutide injection delivers medication directly into subcutaneous tissue, bypassing the digestive system for consistent absorption and predictable dosing. Patients typically inject once weekly, making adherence straightforward. Injected semaglutide begins working within days and reaches peak effectiveness in 4-8 weeks, with PlexusDx pricing at $189/mo month-to-month, or from $149/mo on the 6-month plan regardless of dose level.

Oral semaglutide tablets offer convenience for patients who prefer not to inject, though absorption depends on stomach acid and timing of meals. The oral form requires taking the tablet on an empty stomach 30 minutes before food, which can be challenging during a busy schedule. PlexusDx oral semaglutide is $289/mo month-to-month (or $249/mo on the 6-month plan). Both forms contain the same active medication from licensed 503A compounding pharmacies, so efficacy depends more on consistency and individual physiology than delivery method.

Tirzepatide and Dual-Compound GLP-Squared: Enhanced Results for Some Patients

Tirzepatide activates both GLP-1 and GIP receptors, triggering additional metabolic pathways that may produce greater weight loss than semaglutide alone. Landmark trials demonstrate tirzepatide-treated patients lost 20-22% of body weight compared to 15-17% with semaglutide monotherapy. This dual-pathway activation may benefit patients who don't respond optimally to semaglutide alone. PlexusDx compounded tirzepatide injection is $289/mo month-to-month, or from $249/mo on the 6-month plan.

PlexusDx GLP-Squared combines semaglutide and tirzepatide in a single injection, offering simultaneous activation of GLP-1, GIP, and additional pathways. This advanced option targets patients with complex metabolic needs or those seeking maximum efficacy. GLP-Squared injection is $289/mo month-to-month (or $249/mo on the 3-month plan), and the oral form starts at. Your dose may need to go up. Your price won't—PlexusDx maintains flat monthly pricing across all commitment tiers.

Genetic Testing and Personalized GLP-1 Selection at PlexusDx

The PlexusDx Precision Peptide Genetic Test ($298) analyzes GIPR (rs1800437), FTO (rs9939609), and MC4R (rs17782313) — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to tirzepatide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

The PlexusDx Precision Peptide Genetic Test analyzes FTO — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to GLP-1 medications or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

Starting Your GLP-1 Journey: Dosing, Side Effects, and Timeline

GLP-1 therapy typically begins at a low dose and increases gradually over 4-8 weeks to minimize nausea and digestive side effects. Common initial effects include mild stomach upset, reduced appetite, and occasional headache—symptoms that usually subside within 1-2 weeks as your body adjusts. PlexusDx providers tailor dose escalation based on your tolerance and response, ensuring safe and sustainable progress.

Most patients experience noticeable appetite reduction within 3-5 days of starting semaglutide injection, though maximum weight loss requires consistent use for at least 12 weeks. Results compound over time; clinical data shows continued weight loss up to 68 weeks of continuous therapy. PlexusDx microdose GLP-1 protocol ($129 per month) offers a lower-dose entry point for patients seeking gentle initiation. HSA and FSA accounts are eligible, and no membership fees apply—only the cost of your chosen medication.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

Which GLP-1 medication should I start with: semaglutide or tirzepatide?

Semaglutide is an excellent starting point for most patients seeking reliable, well-studied weight loss and costs less upfront at $189 per month for injection. Tirzepatide ($289/month injection) may suit you better if previous weight loss attempts stalled or if genetic testing reveals strong GIP receptor responsiveness. PlexusDx providers review your medical history and can recommend genetic testing to guide selection.

How much weight can I lose on semaglutide injections?

No — the Precision Peptide Genetic Test does not predict your response to semaglutide or any specific medication. It analyzes pathway-level variants (GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Does PlexusDx offer payment plans or insurance coverage?

PlexusDx serves all 50 states with no insurance required and no membership fees. Semaglutide injection is $189/mo month-to-month (or $149/mo on the 6-month plan), with pricing flat across all commitment tiers—your dose may increase, but your monthly cost won't. HSA and FSA accounts are eligible, and the Precision Peptide Genetic Test adds $298.

What side effects should I expect, and how long do they last?

Most patients experience mild nausea, reduced appetite, or occasional constipation during the first 1-2 weeks as their body adjusts to the medication. These effects typically resolve with time and are often welcomed because reduced appetite supports weight loss goals. Serious side effects are rare; report any persistent vomiting, severe stomach pain, or signs of pancreatitis to your provider immediately.

How does PlexusDx genetic testing help me choose the right GLP-1?

No — the Precision Peptide Genetic Test does not predict your response to tirzepatide or any specific medication. It analyzes pathway-level variants (GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Glp Receptor 1 Agonists
• Glp 1 Receptor Agonists For Weight Loss
• Glp 1 Receptor Agonist List
• Glp 1 Receptor

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.